These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2533220)

  • 21. Decreased skeletal muscle vasodilation in patients with congestive heart failure.
    Imaizumi T; Hirooka Y; Takeshita A
    Jpn Circ J; 1992 May; 56(5):500-3. PubMed ID: 1534858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal and circulatory responses to chronically controlled increments in right atrial pressure.
    Shin Y; Lohmeier TE; Hester RL; Kivlighn SD; Smith MJ
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1176-87. PubMed ID: 1835308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous tone.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Clin Exp Hypertens; 1993 Mar; 15(2):339-54. PubMed ID: 8467321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of captopril on peripheral hemodynamics in severe congestive heart failure.
    Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K
    Clin Exp Hypertens A; 1987; 9(2-3):587-91. PubMed ID: 3301083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
    Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
    MacIntrye IM; Jhund PS; McMurray JJ
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):261-5. PubMed ID: 16187007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure.
    Pedersen EB; Danielsen H; Jensen T; Madsen M; Sørensen SS; Thomsen OO
    Eur J Clin Invest; 1986 Feb; 16(1):56-60. PubMed ID: 3084274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA; Kochsiek K
    Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of atrial natriuretic peptide on vasopressin release.
    Ogawa K; Arnolda LF; Woodcock EA; Hiwatari M; Johnston CI
    Clin Sci (Lond); 1987 May; 72(5):525-30. PubMed ID: 2953525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of inhibition of renin response to hypotension by atrial natriuretic factor.
    Scheuer DA; Thrasher TN; Keil LC; Ramsay DJ
    Am J Physiol; 1989 Jul; 257(1 Pt 2):R194-203. PubMed ID: 2546456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
    Lee ME; Miller WL; Edwards BS; Burnett JC
    J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
    Elijovich F; Laffer CL; Schiffrin EL
    J Hum Hypertens; 1997 May; 11(5):313-9. PubMed ID: 9205939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.